Psoriasis is a chronic, immune-mediated inflammatory skin condition characterised by red, thickened plaques with overlying scale. It occurs due to accelerated skin cell turnover, where skin cells renew in days rather than weeks, leading to inflammation, scaling, and visible skin changes.
Psoriasis affects approximately 2–4% of the population. It is not contagious, but its chronic and visible nature can significantly affect physical comfort, emotional wellbeing, and quality of life. While psoriasis cannot currently be cured, symptoms can often be effectively controlled with appropriate, ongoing management.
Psoriasis can occur at any age, with common peaks in early adulthood and later life. A genetic predisposition plays an important role, and around one-third of affected individuals have a family history of the condition.
The immune system is central to psoriasis development, and symptoms may fluctuate over time with periods of flare and remission.
Psoriasis is an immune-mediated genetic skin disease, involving an interaction between the immune system and genetic predisposition. Certain triggers may worsen psoriasis, including:

Psoriasis may present as:
Commonly affected areas include the scalp, elbows, knees, lower back, palms, and soles, though psoriasis can occur anywhere on the body.
While triggers vary between individuals, flare-ups may be associated with:
Identifying and managing triggers is an important part of long-term control.
Psoriasis management is individualised and depends on disease severity, extent, location, and response to previous treatment. Options may include topical therapy, phototherapy, or systemic treatments.
Phototherapy is a cornerstone treatment for moderate to severe psoriasis and for widespread or treatment-resistant disease.
Narrowband UVB (nbUVB) phototherapy is the most commonly used and well-established form. It involves exposing affected skin to carefully controlled ultraviolet light under medical supervision.
Phototherapy may help:
Treatment is delivered using medical-grade equipment in a clinical setting. Sessions are brief and scheduled over a treatment course to balance effectiveness and safety. For selected cases, other light-based options such as excimer laser or PUVA may be considered.

Depending on severity and response, management may also include:
Your clinician will discuss appropriate options during consultation.
No. Psoriasis cannot be passed from person to person.
Phototherapy may be recommended for individuals with moderate to severe psoriasis, widespread disease, or psoriasis that has not responded adequately to topical treatment. Suitability is assessed during consultation.
When delivered under medical supervision, narrowband UVB phototherapy is generally well tolerated. Potential risks and expected outcomes are discussed prior to treatment.
Many patients notice improvement after several weeks of regular treatment. Response varies between individuals.
There is currently no cure. Treatment focuses on controlling symptoms, reducing flare-ups, and maintaining skin health over time.
Psoriasis is a long-term condition that benefits from ongoing care and regular review. Effective management may include:
If psoriasis is affecting your comfort, confidence, or quality of life, professional assessment is the first step. A consultation with a qualified medical practitioner allows for accurate diagnosis and discussion of personalised treatment options, including medically supervised phototherapy.
Book an appointment to explore evidence-based care designed to help you manage psoriasis with confidence.